Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Hims & Hers Health, Inc. (HIMS) Tops Q4 EPS by 2c, Guidance Tops Views
February 26, 2024 4:10 PM ESTHims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of $, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $246.6 million versus the consensus estimate of $245.82 million.
GUIDANCE:
Hims & Hers Health, Inc. sees Q1 2024 revenue of $267-272... More
